Leadgene Biosolutions (formerly Cytena BPS), founded in 2018, is a specialist provider of advanced micro‑scale bioprocess technologies, including the C.BIRD, C.NEST 2.0 and S.NEST 2.0 systems, designed to support early‑stage development, cell culture optimisation and data‑driven bioprocess decision making. In 2025, the company transitioned into an independent identity through integration with Leadgene Biomedical, uniting academic innovation, international experience and real‑world insight within a unified biosolutions organisation.

Built on engineering innovation and bioprocess understanding, Leadgene develops intelligent, small-scale culture systems that help researchers generate reproducible, process-relevant data relevant to larger-scale bioprocesses. Their technologies are designed to bridge the gap between early research and scalable biomanufacturing.

Leadgene’s systems use micro-scale microbioreactor technology with defined mixing in standard multi-well culture formats. This improves culture consistency compared with static methods and enables high-throughput, parallel experimentation under process-relevant conditions, helping scientists generate higher-quality data and make more confident early-stage development decisions.

Advantages of Leadgene Biosolutions Products